{
  "id" : "grade_post_therapy_path_67342",
  "algorithm" : "eod_public",
  "version" : "2.0",
  "name" : "Grade Post Therapy Path (yp)",
  "title" : "Grade Post Therapy Path (yp)",
  "notes" : "**Note 1:** Leave Grade Post Therapy Path (yp) blank when \n* No neoadjuvant therapy\n* Clinical or pathological case only\n* There is only one grade available and it cannot be determined if it is clinical, pathological, post therapy clin or post therapy path\n\n**Note 2:** Grade is applicable for the follicular lymphomas only (9690/3, 9691/3, 9695/3, 9698/3).  For all other lymphoma histologies, code 9.\n\n**Note 3:** Assign the highest grade from the resected primary tumor assessed after the completion of neoadjuvant therapy.\n\n**Note 4:** If there are multiple tumors with different grades abstracted as one primary, code the highest grade.\n\n**Note 5:** Follicular lymphoma grade is based on the absolute number of centroblasts per high-power (40 x objective, 0.159 square mm) microscopic field (HPF).\n\n**Note 6:** Code 9 (unknown) when \n* Surgical resection is done after neoadjuvant therapy and grade from the primary site is not documented\n* Surgical resection is done after neoadjuvant therapy and there is no residual cancer\n* Grade checked \"not applicable\" on CAP Protocol (if available) and no other grade information is available",
  "last_modified" : "2020-05-29T13:56:08.724Z",
  "definition" : [ {
    "key" : "grade_post_therapy_path",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "1", "G1: 0-5 centroblasts per HPF" ], [ "2", "G2: 6-15 centroblasts per HPF " ], [ "3", "G3: More than 15 centroblasts per 10 HPF but with admixed centrocytes" ], [ "4", "G4: More than 15 centroblasts per 10 HPF but without centrocytes " ], [ "9", "Grade cannot be assessed (GX); Unknown \nNot a follicular histology (9690/3, 9691/3, 9695/3, 9698/3)" ], [ "", "See Note 1" ] ]
}